FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a synergic antimicrobial composition containing flumetsulam and thiabendazole, wherein flumetsulam and thiabendazole are taken in ratio from 8:1 to 1:15.
EFFECT: invention provides higher antimicrobial activity as compared to using each of the ingredients of the composition separately.
4 cl, 2 tbl
Authors
Dates
2015-10-20—Published
2011-11-02—Filed